Clinical Trial Update: The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial) [Phase 3]

View source ↗

Summary

The EuroSTAR Phase 3 trial evaluating a cobalt-based antiproliferative stent for restenosis in symptomatic ischemic heart disease has completed, sponsored by Co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• European Cobalt Stent with antiproliferative coating (EuroSTAR) (cobalt stent with antiproliferative coating)

Snippet

Sponsor: Cordis US Corp. | Conditions: Treatment of Symptomatic Ischemic Heart Disease | Phase 3 | Status: COMPLETED